ARCHIVES

Advisors’ Report On Intramural Program To Recommend Restructuring

This article is from The Cancer Letter archive.

Vol. 21 No. 15 | April 14, 1995

Download PDF Visit The Full Archive

Related Articles

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992